Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?

Journal of Geriatric Oncology

Volumn 5, Issue 3, 2014, Pages 323-330

  Jorgensen, Mikaela L ^a   Young, Jane M ^a,b   Dobbins, Timothy A ^a   Solomon, Michael J ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adjuvant therapy; Age; Chemotherapy; Colorectal cancer; Disparity; Elderly; Older; Radiotherapy; Underutilisation

Indexed keywords

CAPECITABINE;

AGE; AGED; ARTICLE; AUSTRALIA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHARLSON COMORBIDITY INDEX; COLON CANCER; COLORECTAL CANCER; EMERGENCY SURGERY; FEMALE; HEALTH DISPARITY; HEALTH STATUS; HUMAN; INTENSIVE CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER; SEX DIFFERENCE; SINGLE (MARITAL STATUS); ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; CHILD; COLONIC NEOPLASMS; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RECTAL NEOPLASMS; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COLONIC NEOPLASMS; FEMALE; HEALTH STATUS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEW SOUTH WALES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; YOUNG ADULT;

EID: 84905041568     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2014.02.007     Document Type: Article

References (37)

1. Australian Institute of Health and Welfare(AIHW) ACIM (Australian Cancer Incidence and Mortality) Books 2012, AIHW, Canberra, [Available: http://www.aihw.gov.au/acim-books/].
2. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee Guidelines for the prevention, early detection and management of colorectal cancer 2005, The Cancer Council Australia and Australian Cancer Network, Sydney.
3. Young J.M., Leong D.C., Armstrong K., O'Connell D., Armstrong B.K., Spigelman A.D., et al. Concordance with national guidelines for colorectal cancer care in New South Wales: a population-based patterns of care study. Med J Aust 2007, 186:292-295.
4. van Steenbergen L.N., Rutten H.J.T., Creemers G.J., Pruijt J.F.M., Coebergh J.W.W., Lemmens V.E.P.P. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands. Ann Oncol 2010, 21:1273-1278.
5. Chagpar R., Xing Y., Chiang Y.J., Feig B.W., Chang G.J., You Y.N., et al. Adherence to stage-specific treatment guidelines for patients with colon cancer. J Clin Oncol 2012, 30:972-979.
6. Eldin N.S., Yasui Y., Scarfe A., Winget M. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Clin Oncol 2012, 24:e9-e17.
7. Gagliardi G., Pucciarelli S., Asteria C.R., Infantino A., Romano G., Cola B., et al. A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol 2010, 14:229-235.
8. van Steenbergen L.N., Lemmens V.E.P.P., Rutten H.J.T., Wymenga A.N.M., Nortier J.W.R., Janssen-Heijnen M.L.G. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in the Netherlands. Ann Oncol 2012, 23:2805-2811.
9. Mak R.H., McCarthy E.P., Das P., Hong T.S., Mamon H.J., Hoffman K.E. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance. Epidemiology, and End Results patterns-of-care study, Int J Radiat Oncol Biol Phys 2011, 80:978-984.
10. Young J., Jorgensen M., Dobbins T., Solomon M. CESR Technical Report 1: The quality and usefulness of the NSW Clinical Cancer Registry Minimum Dataset and Colorectal Dataset Extension for colorectal cancer services research 2012, Sydney School of Public Health, The University of Sydney, Sydney, [Available: http://hdl.handle.net/2123/8936].
11. Rabe-Hesketh S., Skrondal A. Multilevel and longitudinal modelling using Stata 2008, Stata Press, Texas. 2nd ed.
12. Charlson M.E., Pompei P., Ales K.A., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
13. Pink B. Socio-economic indexes for areas (SEIFA). Technical Paper, 2006 2008, Australian Bureau of Statistics, Canberra, [Available: http://www.abs.gov.au/ausstats/abs.nsf/mf/2039.0.55.001/].
14. Department of Health Aged Care Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA) Revised Edition. Occasional Papers: New Series No. 14 2001, Commonwealth of Australia, [Available: http://www.health.gov.au].
15. Cancer Council N.S.W. Improving radiotherapy: where to from here? A roadmap for the NSW Government 2009, The Cancer Council NSW, Sydney, [Available: http://www.cancercouncil.com.au/wp-content/uploads/2011/10/Improving-Radiotherapy_Roadmap_May-2009.pdf].
16. Kristjansson S.R., Jordhøy M.S., Nesbakken A., Skovlund E., Bakka A., Johannessen H.O., et al. Which elements of a comprehensive geriatric assessment (CGA) predict post-operative complications and early mortality after colorectal cancer surgery?. J Geriatr Oncol 2010, 1:57-65.
17. Mayr R., May M., Martini T., Lodde M., Pycha A., Comploj E., et al. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int 2012, 110:E222-E227.
18. Van Gils C.W.M., Koopman M., Mol L., Redekop W.K., Uyl-De Groot C.A., Punt C.J.A. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in the Netherlands. Acta Oncol 2012, 51:57-64.
19. Ananda S., Field K.M., Kosmider S., Compston D., Desai J., Lim L.C., et al. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice. J Clin Oncol 2008, 26:4516-4517.
20. Goldsbury D.E., Armstrong K., Simonella L., Armstrong B.K., O'Connell D.L. Using administrative health data to describe colorectal and lung cancer care in New South Wales, Australia: a validation study. BMC Health Serv Res 2012, 12:387.
21. Boxer M.M., Vinod S.K., Shafiq J., Duggan K.J. Do multidisciplinary team meetings make a difference in the management of lung cancer?. Cancer 2011, 117:5112-5120.
22. Jones A.P., Haynes R., Sauerzapf V., Crawford S.M., Zhao H., Forman D. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer 2008, 44:992-999.
23. Armstrong K., O'Connell D.L., Leong D., Spigelman A.D., Armstrong B.K. The New South Wales Colorectal Cancer Care Survey 2000: Part 1. Surgical management 2004, The Cancer Council New South Wales, Sydney.
24. Lima I.S.F., Yasui Y., Scarfe A., Winget M. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Cancer 2011, 117:3833-3840.
25. Bouvier A.M., Minicozzi P., Grosclaude P., Bouvier V., Faivre J., Sant M. Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy. Dig Liver Dis 2013, 45:687-691.
26. Elferink M.A., van Steenbergen L.N., Krijnen P., Lemmens V.E., Rutten H.J., Marijnen C.A., et al. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer 2010, 46:1421-1429.
27. Schrag D., Gelfand S.E., Bach P.B., Guillem J., Minsky B.D., Begg C.B. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from Surveillance, Epidemiology, and End Results-Medicare. J Clin Oncol 2001, 19:3712-3718.
28. Gross C.P., McAvay G.J., Krumholz H.M., Paltiel A.D., Bhasin D., Tinetti M.E. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med 2006, 145:646-653.
29. Jorgensen M.L., Young J.M., Solomon M.J. Older patients and adjuvant therapy for colorectal cancer: surgeon knowledge, opinions, and practice. Dis Colon Rectum 2011, 54:335-341.
30. Krzyzanowska M.K., Regan M.M., Powell M., Earle C.C., Weeks J.C. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg 2009, 208:202-209.
31. Quipourt V., Jooste V., Cottet V., Faivre J., Bouvier A. Comorbidities alone do not explain the undertreatment of colorectal cancer in older adults: a French population-based study. J Am Geriatr Soc 2011, 59:694-698.
32. Luo R., Giordano S.H., Freeman J.L., Zhang D., Goodwin J.S. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist 2006, 11:1025-1033.
33. Abraham N.S., Gossey J.T., Davila J.A., Al-Oudat S., Kramer J.K. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol 2006, 101:1320-1328.
34. MacDermid E., Hooton G., MacDonald M., McKay G., Grose D., Mohammed N., et al. Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis 2009, 11:291-295.
35. Gill S., Loprinzi C.L., Sargent D.J., Thomé S.D., Alberts S.R., Haller D.G., et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?. J Clin Oncol 2004, 22:1797-1806.
36. Gray R., Hills R., Stowe R. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 2001, 358:1291-1304.
37. Barton M.B., Delaney G.P. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?. J Med Imaging Radiat Oncol 2011, 55:433-441.